Literature DB >> 34816677

The pronounced decline of anti-SARS-CoV-2 spike trimeric IgG and RBD IgG in baseline seronegative individuals six months after BNT162b2 vaccination is consistent with the need for vaccine boosters.

Gian Luca Salvagno1,2, Brandon M Henry3,4, Laura Pighi1,2, Simone De Nitto1,2, Gianluca Gianfilippi5, Giuseppe Lippi1.   

Abstract

Entities:  

Keywords:  COVID-19; SARS-CoV-2; antibodies; immune response; vaccination

Mesh：

Substances：

Year:  2021        PMID： 34816677     DOI： 10.1515/cclm-2021-1184

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN： 1434-6621            Impact factor:   3.694


× No keyword cloud information.
  10 in total

1.  Six months SARS-CoV-2 serology in a cohort of mRNA vaccinated subjects over 90 years old.

Authors:  Rossella Tomaiuolo; Chiara Di Resta; Marco Viganò; Giuseppe Banfi; Cristina Russo; Giulia Linardos; Stefania Ranno; Carlo Federico Perno; Francesco Giuffrida
Journal:  Sci Rep       Date:  2022-07-20       Impact factor: 4.996

2.  Differential Dynamics of SARS-CoV-2 Binding and Functional Antibodies upon BNT162b2 Vaccine: A 6-Month Follow-Up.

Authors:  Giulia Matusali; Giuseppe Sberna; Silvia Meschi; Giulia Gramigna; Francesca Colavita; Daniele Lapa; Massimo Francalancia; Aurora Bettini; Maria R Capobianchi; Vincenzo Puro; Concetta Castilletti; Francesco Vaia; Licia Bordi
Journal:  Viruses       Date:  2022-02-02       Impact factor: 5.048

3.  Two rapid SARS-CoV-2 disposable devices for semi-quantitative S-RBD antibody levels determination compared with CLIA and ELISA assays at different protective thresholds.

Authors:  Andrea Padoan; Chiara Cosma; Luisa Galla; Daniela Basso; Mario Plebani
Journal:  Clin Chim Acta       Date:  2022-02-21       Impact factor: 3.786

4.  Safety and Long-Term Immunogenicity of BNT162b2 Vaccine in Individuals with Down Syndrome.

Authors:  Diletta Valentini; Nicola Cotugno; Vittorio Scoppola; Chiara Di Camillo; Luna Colagrossi; Emma Concetta Manno; Carlo Federico Perno; Cristina Russo; Paolo Palma; Paolo Rossi; Alberto Villani
Journal:  J Clin Med       Date:  2022-01-28       Impact factor: 4.241

Review 5.  Characterization of the significant decline in humoral immune response six months post-SARS-CoV-2 mRNA vaccination: A systematic review.

Authors:  Kin Israel Notarte; Israel Guerrero-Arguero; Jacqueline Veronica Velasco; Abbygail Therese Ver; Maria Helena Santos de Oliveira; Jesus Alfonso Catahay; Md Siddiqur Rahman Khan; Adriel Pastrana; Grzegorz Juszczyk; Jordi B Torrelles; Giuseppe Lippi; Luis Martinez-Sobrido; Brandon Michael Henry
Journal:  J Med Virol       Date:  2022-03-09       Impact factor: 20.693

6.  Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants.

Authors:  Anu Kantele; Johanna Lempainen; Laura Kakkola; Pekka Kolehmainen; Ilkka Julkunen; Milja Belik; Pinja Jalkanen; Rickard Lundberg; Arttu Reinholm; Larissa Laine; Elina Väisänen; Marika Skön; Paula A Tähtinen; Lauri Ivaska; Sari H Pakkanen; Hanni K Häkkinen; Eeva Ortamo; Arja Pasternack; Mikael A Ritvos; Rauno A Naves; Simo Miettinen; Tarja Sironen; Olli Vapalahti; Olli Ritvos; Pamela Österlund
Journal:  Nat Commun       Date:  2022-05-05       Impact factor: 17.694

Review 7.  Strategies and safety considerations of booster vaccination in COVID-19.

Authors:  Hanyan Meng; Jianhua Mao; Qing Ye
Journal:  Bosn J Basic Med Sci       Date:  2022-06-01       Impact factor: 3.759

8.  Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial results.

Authors:  Chiara Agrati; Concetta Castilletti; Simone Battella; Eleonora Cimini; Giulia Matusali; Andrea Sommella; Alessandra Sacchi; Francesca Colavita; Alessandra M Contino; Veronica Bordoni; Silvia Meschi; Giulia Gramigna; Federica Barra; Germana Grassi; Licia Bordi; Daniele Lapa; Stefania Notari; Rita Casetti; Aurora Bettini; Massimo Francalancia; Federica Ciufoli; Alessandra Vergori; Serena Vita; Michela Gentile; Angelo Raggioli; Maria M Plazzi; Antonella Bacchieri; Emanuele Nicastri; Andrea Antinori; Stefano Milleri; Simone Lanini; Stefano Colloca; Enrico Girardi; Roberto Camerini; Giuseppe Ippolito; Francesco Vaia; Antonella Folgori; Stefania Capone
Journal:  NPJ Vaccines       Date:  2022-09-24       Impact factor: 9.399

9.  Efficacy of COVID-19 vaccine booster doses in older people.

Authors:  Camilla Mattiuzzi; Giuseppe Lippi
Journal:  Eur Geriatr Med       Date:  2022-01-24       Impact factor: 3.269

10.  Durability of Humoral Responses after the Second Dose of mRNA BNT162b2 Vaccine in Residents of a Long Term Care Facility.

Authors:  Alessia Lai; Barbara Caimi; Marco Franzetti; Annalisa Bergna; Rossella Velleca; Antonella Gatti; Pier Luigi Rossi; Marco D'Orso; Fabrizio Pregliasco; Claudia Balotta; Giuseppe Calicchio
Journal:  Vaccines (Basel)       Date:  2022-03-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.